Advertisement

Commentary: Preoperative tobacco burden—a risk factor, but not a roadblock for safe resection

  • Matthew A. Steliga
    Correspondence
    Address for reprints: Matthew A. Steliga, MD, Division of Thoracic Surgery, Department of Surgery, University of Arkansas for Medical Sciences, 4301 W Markham St #725, Little Rock, AR 72205.
    Affiliations
    Division of Thoracic Surgery, University of Arkansas, Little Rock, Ark
    Search for articles by this author
Published:December 03, 2020DOI:https://doi.org/10.1016/j.jtcvs.2020.11.134
      This statewide collaborative study demonstrates that current smoking status does not impact short-term outcomes on lung cancer resection, and surgery can be done without increased risk in these patients.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to The Journal of Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Al Natour R.H.
        • He C.
        • Clark M.J.
        • Welsh R.
        • Chang A.C.
        • Adams K.N.
        The impact of tobacco load versus smoking status on outcomes following lobectomy for lung cancer in a statewide quality collaborative.
        J Thorac Cardiovasc Surg. 2021; 162: 1375-1385.e1
        • Warren G.W.
        • Sobus S.
        • Gritz E.R.
        The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support.
        Lancet Oncol. 2014; 15: e568-e580
        • Aberle D.R.
        • Adams A.M.
        • Berg C.D.
        • Black W.C.
        • Clapp J.D.
        • et al.
        • National Lung Screening Trial Research Team
        Reduced lung-cancer mortality with low-dose computed tomographic screening.
        N Engl J Med. 2011; 365: 395-409
        • National Comprehensive Cancer Network
        NCCN Clinical practice guidelines in non–small cell lung cancer. Version 8.2020.
        (Available at:)

      Linked Article